Self-terminating AF depends on electrical remodeling while persistent AF depends on additional structural changes in a rapid atrially paced sheep model

被引:104
作者
Anne, Wirn
Willems, Rik
Holemans, Patricia
Beckers, Frank
Roskams, Tania
Lenaerts, Ilse
Ector, Hugo
Heidbuchel, Hein
机构
[1] Univ Leuven, Univ Hosp Gasthuisberg, Dept Cardiol, B-3000 Louvain, Belgium
[2] Univ Leuven, Univ Hosp Gasthuisberg, Dept Pathol, B-3000 Louvain, Belgium
关键词
angiotensin; arrhythmia (mechanisms); fibrosis; remodeling; matrix metalloprotemases;
D O I
10.1016/j.yjmcc.2007.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of atrial fibrillation (AF) is associated with electrical and structural remodeling. The aim of this study was to assess the contribution of electrical and structural remodeling to the development of AF in a rapid atrially paced ovine model with and without His bundle ablation and to determine the role of the angiotensin pathway and matrix metalloproteinases in this process. Thirty-five sheep were rapidly paced in the atrium and were randomized to undergo His bundle ablation (HBA) (21 sheep; HBA sheep) or not (14 sheep; non-HBA sheep). After HBA the ventricles were paced at 80 bpm. Both groups were subdivided to receive active treatment (quinapril+losartan) or placebo. Sheep were followed for 15 weeks. Inducible AF was defined as a rapid irregular atrial rhythm lasting > 1 min. Inducible AF was considered to be persistent if during further follow-up no sinus rhythm (SR) was documented anymore. The inducibility of AF with atrial tachypacing was not different between the 4 groups. On the other hand, non-HBA sheep developed persistent AF significantly earlier than HBA sheep (p=0.028). They had elevated ventricular rates, diminished atrial MMP-2, increased TIMP-2 expression, and more extensive atrial fibrosis. Active treatment in these sheep significantly lowered AT-II (p=0.018), prevented atrial fibrogenesis (p < 0.001) and slowed the development of persistent AF (p=0.049). Electrical remodeling is sufficient to induce AF, while structural changes are needed for persistent AF. Fibrosis development in our model is the result of an increased expression of AT-II in combination with changes in MMP expression. Inhibition of the angiotensin pathway suppresses atrial fibrosis and the development of persistent AF. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:148 / 158
页数:11
相关论文
共 30 条
[1]   Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease [J].
Ahmed, SH ;
Clark, LL ;
Pennington, WR ;
Webb, CS ;
Bonnema, DD ;
Leonardi, AH ;
McClure, CD ;
Spinale, FG ;
Zile, MR .
CIRCULATION, 2006, 113 (17) :2089-2096
[2]   Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation [J].
Anné, W ;
Willems, R ;
Roskams, T ;
Sergeant, P ;
Herijgers, P ;
Holemans, P ;
Ector, H ;
Heidbüchel, H .
CARDIOVASCULAR RESEARCH, 2005, 67 (04) :655-666
[3]   Atrial fibrillation after radiofrequency ablation of atrial flutter:: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics [J].
Anné, W ;
Willems, R ;
Van der Merwe, N ;
Van de Werf, F ;
Ector, H ;
Heidbüchel, H .
HEART, 2004, 90 (09) :1025-1030
[4]   Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat [J].
Boixel, C ;
Fontaine, V ;
Rücker-Martin, C ;
Milliez, P ;
Louedec, L ;
Michel, JB ;
Jacob, MP ;
Hatem, SN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :336-344
[5]   Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation [J].
Goette, A ;
Staack, T ;
Röcken, C ;
Arndt, M ;
Geller, JC ;
Huth, C ;
Ansorge, S ;
Klein, HU ;
Lendeckel, U .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) :1669-1677
[6]   Wavelength and atrial vulnerability: an endocavitary approach in humans [J].
Graux, P ;
Carlioz, R ;
Rivat, P ;
Bera, J ;
Guyomar, Y ;
Dutoit, A .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (01) :202-208
[7]   Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction [J].
Kim, YK ;
Mankad, S ;
Kim, SJ ;
Takagi, G ;
Tamura, T ;
Gerdes, AM ;
Bishop, SP ;
Kramer, CM .
JOURNAL OF CARDIAC FAILURE, 2003, 9 (03) :238-245
[8]   Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation [J].
Kumagai, K ;
Nakashima, H ;
Urata, H ;
Gondo, N ;
Arakawa, K ;
Saku, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2197-2204
[9]   QUANTIFICATION OF SPATIAL INHOMOGENEITY IN CONDUCTION AND INITIATION OF REENTRANT ATRIAL ARRHYTHMIAS [J].
LAMMERS, WJEP ;
SCHALIJ, MJ ;
KIRCHHOF, CJHJ ;
ALLESSIE, MA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (04) :H1254-H1263
[10]   Effects of experimental heart failure on atrial cellular and ionic electrophysiology [J].
Li, DS ;
Melnyk, P ;
Feng, JL ;
Wang, ZG ;
Petrecca, K ;
Shrier, A ;
Nattel, S .
CIRCULATION, 2000, 101 (22) :2631-2638